UHRF1BP1 Activators
The activators for UHRF1 Binding Protein 1 (UHRF1BP1) target a range of cellular processes and signaling pathways, thereby indirectly influencing UHRF1BP1 activity. These compounds mainly act on epigenetic regulation and developmental signaling pathways. DNA methyltransferase inhibitors like 5-Azacytidine and HDAC inhibitors such as Trichostatin A can modulate chromatin structure and gene expression, impacting UHRF1BP1's interaction with UHRF1 and its role in epigenetic regulation. EZH2 inhibitors and BET bromodomain inhibitors affect chromatin modifications and transcriptional regulation, which could indirectly influence UHRF1BP1.
LSD1 inhibitors impact histone methylation, a key epigenetic mark, possibly affecting UHRF1BP1's role in gene regulation. Modulators of developmental pathways like Wnt, Hedgehog, NOTCH, and TGF-beta could also indirectly impact UHRF1BP1's function in these processes. Inhibitors of signaling pathways such as JAK/STAT, mTOR, and PI3K/Akt, known for their roles in cell growth, differentiation, and survival, might also have indirect effects on UHRF1BP1. These compounds do not specifically target UHRF1BP1 but influence cellular processes and pathways that could modulate UHRF1BP1's activity or expression. Understanding the impact of these compounds on UHRF1BP1 requires further research and could provide insights into strategies for conditions where UHRF1BP1's regulation is implicated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
These inhibitors can alter DNA methylation patterns, potentially impacting UHRF1BP1's interaction with UHRF1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitors affect chromatin structure and gene expression, potentially influencing UHRF1BP1. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
Modulating the Wnt signaling pathway could indirectly affect UHRF1BP1's role in development. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Inhibiting Hedgehog signaling may impact developmental processes involving UHRF1BP1. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
NOTCH signaling is crucial in development, and its inhibition could indirectly affect UHRF1BP1. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
By inhibiting JAK/STAT signaling, these compounds might influence processes involving UHRF1BP1. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Modulating TGF-beta signaling could impact cellular processes relevant to UHRF1BP1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As mTOR inhibitors affect cell growth and differentiation, they might indirectly influence UHRF1BP1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibiting the PI3K/Akt pathway could indirectly affect UHRF1BP1 through various signaling pathways. | ||||||